pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·10h ago·1 min read
save

Fauci invokes Fifth Amendment, declines to answer Covid-19 origins questions at Senate hearing

Jul 29, 2026·read at STAT ↗RegulatoryNeutral

At a Senate hearing on Wednesday, former U.S. health chief Anthony Fauci invoked his Fifth Amendment right and refused to answer lawmakers' questions about the Covid-19 pandemic and its origins.

Fauci said his decision was based on advice from his attorneys after being subpoenaed to testify about the government's pandemic response.

The move was described by some senators as part of a broader inquiry into the virus's origins, while others framed it as a political tactic.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Fauci invokes Fifth Amendment in declining to answer questions before Senate panel”

read at STAT ↗
1,062 words · retrieved 10h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 2h agoNSF testing new Ph.D. model giving trainees academic and industry experienceSTAT
  • 2h agoSTAT+: Latigo reports mid-stage success for would-be rival to Vertex’s pain drug JournavxSTAT
  • 4h agoSTAT+: Hims misled consumers and violated their privacy, FTC alleges in a lawsuitSTAT
  • 8h agoSTAT+: End of Medicare drug subsidy gives Democrats new attack line on rising out-of-pocket costsSTAT
  • 10h agoSTAT+: Pharmalittle: We’re reading about a fugitive who became a biotech exec, a hospital suing Lilly, and moreSTAT